Expression of CD11c and EMR2 on neutrophils: Potential diagnostic biomarkers for sepsis and systemic inflammation

Clinical and Experimental Immunology

Volumn 182, Issue 2, 2015, Pages 184-194

  Lewis, S M ^a,b   Treacher, D F ^a   Edgeworth, J ^b   Mahalingam, G ^b   Brown, C S ^a   Mare, T A ^a,b   Stacey, M ^b   Beale, R ^a,b   Brown, K A ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Biomarkers; Diagnosis, neutrophils; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CD64 ANTIGEN; CD97 ANTIGEN; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN P 15095; HORMONE RECEPTOR; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MUCIN LIKE HORMONE RECEPTOR 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; EMR2 PROTEIN, HUMAN; FC RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ADULT; ANTIGEN EXPRESSION; APACHE; ARTICLE; BACTERIAL INFECTION; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; AGED; BLOOD; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; ANTIGENS, CD11C; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; FEMALE; FLOW CYTOMETRY; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, IGG; RETROSPECTIVE STUDIES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84944041273     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12679     Document Type: Article

References (52)

1. Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-96.
2. Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165-228.
3. Vincent J-L, Opal SO, Marshall JC, Tracey KJ. Sepsis definitions, time for a change. Lancet 2013; 381:774-5.
4. Paterson RL, Webster NR. Sepsis and the systemic inflammatory response syndrome. J R Coll Surg Edinb 2000; 45:178-82.
5. Su L, Han B, Liu C et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 2012; 12:157.
6. Gibot S, Béné MC, Noel R et al. Combination biomarkers to diagnose sepsis in the critically ill patient. Am J Respir Crit Care Med 2012; 186:65-71.
7. Bloos F. Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays. Methods Mol Biol 2015; 1237:247-60.
8. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006; 368:157-69.
9. Langer HF, Chavakis T. Leukocyte-Endothelial Interactions in Inflammation. J Cell Mol Med 2009; 13:1211-20.
10. Lin RY, Astiz ME, Saxon JC, Rackow EC. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 1993; 104:847-53.
11. Rosenbloom AJ, Pinsky MR, Napolitano C et al. Suppression of cytokine-mediated beta2 -integrin activation on circulating neutrophils in critically ill patients. J Leukoc Biol 1999; 66:83-9.
12. Muller Kobold AC, Tulleken JE, Zijlstra JG et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 2000; 26:883-92.
13. Chishti AD, Shenton BK, Kirby JA, Baudouin SV. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med 2004; 30:605-11.
14. Tansho-Nagakawa S, Ubagai T, Kikuchi-Ueda T, Koshio O, Koshibu Y Kikuchi H. Analysis of membrane antigens on neutrophils from patients with sepsis. J Infect Chemother 2012; 18:646-56.
15. Qureshi SS, Lewis SM, Gant VA, Treacher D, Davis BH, Brown KA. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol 2001; 125:258-65.
16. Fadlon E, Vordermeier S, Pearson TC et al. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 1998; 91:266-74.
17. Frick C, Odermatt A, Zen K et al. Interaction of ICAM-1 with beta 2-integrin CD11c/CD18: characterization of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1. Eur J Immunol 2005; 35:3610-21.
18. Bjarnadóttir TK, Fredriksson R, Höglund PJ, Gloriam DE, Lagerström MC, Schiöth HB. The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. Genomics 2004; 84:23-33.
19. Kwakkenbos MJ, Kop EN, Stacey M et al. The EGF-TM7 family: a postgenomic view. Immunogenetics 2004; 55:655-66.
20. Stacey M, Chang G-W, Davies JQ et al. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 2003; 102:2916-24.
21. Yona S, Lin H-H, Dri P et al. Ligation of the adhesion-GPCR EMR2 regulates human neutrophil function. Faseb J 2008; 22:741-51.
22. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003; 31:1250-6.
23. Macey M, McCarthy D, Azam U, Milne T, Golledge P, Newland A. Ethylenediamine tetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood. Cytometry 2003; 51:30-40.
24. Icardi M, Erickson Y, Kilborn S, Stewart B, Grief B, Scharnweber G. CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol 2009; 47:3914-9.
25. Hsu KH, Chan MC, Wang JM, Lin LY, Wu CL. Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 2011; 16:152-60.
26. Rogina P, Stubljar D, Lejko-Zupanc T, Osredkar J, Skvarc M. Expression of CD64 on neutrophils (CD64 index): diagnostic accuracy of CD64 index to predict sepsis in critically ill patients. Clin Chem Lab Med 2015; 53:e89-91.
27. Stubljar D, Skvarc M. Expression of CD64 on neutrophils can be used to predict the severity of bloodstream infection before broad range 16S rRNA PCR. Folia Microbiol 2014; 60:111-8.
28. Gros A, Roussel M, Sauvadet E et al. The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients. Intensive Care Med 2012; 38:445-52.
29. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39:206-17.
30. Ten OJ, Tromp M, Bleeker-Rovers CP et al. Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections. J Infect 2012; 13:6-11.
31. Caimi G, Montana M, Citarrella R, Porretto F, Catania A, Lo Presti R. Polymorphonuclear leukocyte integrin profile in diabetes mellitus. Clin Hemorheol Microcirc 2002; 27: 83-9.
32. Hansen PS, Madsen PH, Petersen SB, Nielsen H. Inflammatory activation of neutrophils by Helicobacter pylori; a mechanism insensitive to pertussis toxin. Clin Exp Immunol 2001; 123:73-80.
33. Villa-Ambriz J, Rodríguez-Orozco AR, Béjar-Lozano C, Cortés-Rojo C. The increased expression of CD11c and CD103 molecules in the neutrophils of peripheral blood treated with a formula of bacterial ribosomes and proteoglycans of Klebsiella pneumoniae. Arch Bronconeumo 2012; 48:316-9.
34. Pan W, Shi C, Tian M, Yu J. Anti-CD11c antibody, Efalizumab attenuates ventilator-induced lung injury. Eur Rev Med Pharmacol Sci 2014; 18:2182-90.
35. Netea M, van der Meer JWM, van Deuren M, Kullberg BJ. Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol 2003; 24:254-8.
36. Ward PA. The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4:133-42.
37. Menegazzi R, Busetto S, Decleva E, Cramer R, Dri P, Patriarca P. Triggering of chloride ion efflux from human neutrophils as a novel function of leukocyte beta2 integrins: relationship with spreading and activation of the respiratory burst. J Immunol 1999; 162:423-34.
38. Ruf A, Patscheke H. Platelet-induced neutrophil activation: platelet-expressed fibrinogen induces the oxidative burst in neutrophils by an interaction with CD11C/CD18. Br J Haematol 1995; 90:791-6.
39. Nakamori Y, Koh T, Ogura H et al. Enhanced expression of intranuclear NF-kappa B in primed polymorphonuclear leukocytes in systemic inflammatory response syndrome patients. J Trauma 2003; 54:253-60.
40. Lin HH, Stacey M, Hamann J, Gordon S, McKnight AJ. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97. Genomics 2000 15; 67:188-200.
41. Kop EN, Kwakkenbos MJ, Teske GJD et al. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue. Arthritis Rheum 2005; 52:442-50.
42. Chen T-Y, Hwang T-L, Lin C-Y et al. EMR2 receptor ligation modulates cytokine secretion profiles and cell survival of lipopolysaccharide-treated neutrophils. Chang Gung Med J 2011; 34:468-77.
43. Huang Y-S, Chiang N-Y, Hu C-H et al. Activation of myeloid cell-specific adhesion class G protein-coupled receptor EMR2 via ligation-induced translocation and interaction of receptor subunits in lipid raft microdomains. Mol Cell Biol 2012; 32:1408-20.
44. Shen L, Guyre PM, Fanger MW. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J Immunol 1987; 139:534-8.
45. Quayle JA, Watson F, Bucknall RC, Edwards SW. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression. Immunol 1997; 91:266-73.
46. Herra CM, Keane CT, Whelan A. Increased expression of Fc gamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 1996; 44:135-40.
47. Leino L, Sorvajärvi K, Katajisto J et al. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin Exp Immunol 1997; 107:37-43.
48. Macey MG, McCarthy DA, Vordermeier S, Newland AC, Brown KA. Effects of cell purification methods on CD11b and L-selectin expression as well as the adherence and activation of leucocytes. J Immunol Methods 1995; 181:211-9.
49. Alvarez-Larrán A, Toll T, Rives S, Estella J. Assessment of neutrophil activation in whole blood by flow cytometry. Clin Lab Haematol 2005; 27:41-6.
50. Fridlender ZG, Sun J, Kim S et al. Polarization of tumor-associated neutrophil (TAN) phenotype by TGF-β: 'N1' versus 'N2' TAN. Cancer Cell 2010; 16:183-94.
51. Denny MF, Yalavartha S, Zhao W, Thakar SG, Anderson M Sandy AR. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I interferons. J Immunol 2010; 184:3284-97.
52. Pillay J, Kamp VM, van Hoffen E et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012; 122:327-35.